CN102526398A - Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation - Google Patents
Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN102526398A CN102526398A CN2012100212218A CN201210021221A CN102526398A CN 102526398 A CN102526398 A CN 102526398A CN 2012100212218 A CN2012100212218 A CN 2012100212218A CN 201210021221 A CN201210021221 A CN 201210021221A CN 102526398 A CN102526398 A CN 102526398A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chronic pelvic
- processed
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation. The externally-used traditional Chinese medicinal preparation for treating the chronic pelvic inflammation comprises the following medicinal raw materials in part by weight: 3-9 parts of obscured homalomena rhizome, 3-9 parts of Capsicum Annuum, 3-9 parts of notopterygium, 3-9 parts of radix angelicae pubescentis, 3-9 parts of safflower, 3-9 parts of sangusis draconis, 3-9 parts of Schizophragma integrifolium, 5-15 parts of Angelica dahurica, 5-15 parts of folium artemisiae argyi, 9-15 parts of root of common peony, 9-15 parts of parasitic loranthus, 9-15 parts of cortex acanthopanacis, 9-15 parts of radix saposhnikoviae, 9-10 parts of prepared frankincense, 9-15 parts of prepared myrrh and 50-150 parts of garden balsam stem. During treatment, medicinal powder is put into a gauze bag, evaporated to be dry and thermally smeared on a wound once every day, with about 30 minutes for each time; 15 days is one course of treatment; and generally, the wound can be cured by 1-3 courses of treatments. The externally-used traditional Chinese medicinal preparation for treating the chronic pelvic inflammation is relatively strong in targeting property and good in therapeutic effect; and after a plurality of years of clinical application, the total effective rate is about 90% and the therapeutic effect is very good.
Description
Technical field
The present invention relates to a kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease.
Background technology
Female internal genital organs (uterus, ovary, fallopian tube) and tissue on every side, pelvic cavity, be called pelvic inflammatory disease when peritoneum is inflamed, chronic pelvic inflammatory disease is that acute pelvic inflammatory disease fails thoroughly to cure or sick the kind due to the delay, when Abwehrkraft des Koepers is relatively poor, can show effect.Chronic pelvic inflammatory disease has hypogastric region dull pain and tenesmus, with lumbosacral aching pain, leucorrhoea grow in quantity, menoxenia.Gynecologial examination can touch inflammatory mass in various degree at pelvic cavity, brings very big inconvenience to patient's work and life.At present; It is main that the treatment primary disease adopts the antibiosis anti-inflammatory drug of doctor trained in Western medicine more; Though the state of an illness is control to some extent temporarily, is prone to recurrence, and the antibiosis anti-inflammatory drug of doctor trained in Western medicine has great harm to liver, the kidney of human body; The administration time elder also might cause other complication, and there is problem such as cost an arm and a leg, drug treatment is long, produce effects slowly in the doctor trained in Western medicine antibiotic medicine.
Summary of the invention
To above-mentioned prior art, the invention provides a kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease, its therapeutic effect is good, and cost is low, has no side effect short treating period.
The present invention realizes through following technical scheme:
A kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease is made up of following bulk drugs: 3～9 parts of Rhizoma Homalomenaes, 3～9 parts of Fructus Zanthoxylis, 3～9 parts of Rhizoma Et Radix Notopterygiis, 3～9 parts of Radix Angelicae Pubescentiss; 3～9 parts on Flos Carthami, 3～9 parts of Sanguis Draxonis, 3～9 parts of Cortex schizophragmatis integrifolii radiciss, 5～15 parts of the Radixs Angelicae Dahuricae; 5～15 parts of Folium Artemisiae Argyis, 9～15 parts of Radix Paeoniae Rubra, 9～15 parts of Herba Taxillis, 9～15 parts of Cortex Acanthopanciss; Windproof 9～15 parts, 9～10 parts of Olibanum (processed)s, 9～15 parts of Myrrha (processed)s, 50～150 parts of Herba speranskiae tuberculataes.
Preferably, form: Rhizoma Homalomenae 3g, Fructus Zanthoxyli 3g, Rhizoma Et Radix Notopterygii 3g, Radix Angelicae Pubescentis 3g, Flos Carthami 3g, Sanguis Draxonis 3g, Cortex schizophragmatis integrifolii radicis 3g, Radix Angelicae Dahuricae 5g, Folium Artemisiae Argyi 5g, Radix Paeoniae Rubra 9g, Herba Taxilli 9g, Cortex Acanthopancis 9g, windproof 9g, Olibanum (processed) 9g, Myrrha (processed) 9g, Herba speranskiae tuberculatae 50g by following crude drug.
Preferably, form: Rhizoma Homalomenae 6g, Fructus Zanthoxyli 6g, Rhizoma Et Radix Notopterygii 6g, Radix Angelicae Pubescentis 6g, Flos Carthami 6g by following crude drug; Sanguis Draxonis 6g, Cortex schizophragmatis integrifolii radicis 6g, Radix Angelicae Dahuricae 10g, Folium Artemisiae Argyi 10g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g; Cortex Acanthopancis 12g, windproof 12g, Olibanum (processed) 12g, Myrrha (processed) 12g, Herba speranskiae tuberculatae 100g.
Preferably, form: Rhizoma Homalomenae 15g, Fructus Zanthoxyli 15g, Rhizoma Et Radix Notopterygii 15g, Radix Angelicae Pubescentis 15g, Flos Carthami 15g by following crude drug; Sanguis Draxonis 15g, Cortex schizophragmatis integrifolii radicis 15g, Radix Angelicae Dahuricae 15g, Folium Artemisiae Argyi 15g, Radix Paeoniae Rubra 15g, Herba Taxilli 15g; Cortex Acanthopancis 15g, windproof 15g, Olibanum (processed) 15g, Myrrha (processed) 15g, Herba speranskiae tuberculatae 150g.
The method for preparing of the Chinese medicine for external application of said treatment chronic pelvic inflammatory disease is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, promptly get.
The Chinese medicine for external application of treatment chronic pelvic inflammatory disease of the present invention cures mainly chronic pelvic inflammatory disease, during treatment; Medicated powder is packed in the gauze bag, after the dry blowing in the affected part hot compress, each about 30 minutes; Once a day; Each potion (amount of above-mentioned preferred prescription is the amount of potion), 15 days is a course of treatment, can cure general 1～3 course of treatment.
In the prescription of the present invention, the pharmacology and the mechanism of action of each crude drug are following:
Rhizoma Homalomenae: wind-damp dispelling, bone and muscle strengthening, be used for wind-cold-dampness ache, primary disease belongs to part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels deficiency and coldness mostly, and YANG QI deficiency causes that damp-heat in lower-JIAO also is the performance of primary disease sometimes.
Fructus Zanthoxyli: cold expelling dampness, be used for stomach abdomen cold type of pain, cold stomachache of a specified duration, there are the many persons of leucorrhea to use it, few abdomen cold type of pain that the treatment insufficiency of kidney-YANG causes.Fructus Zanthoxyli property is pungent and warm, the kind sombre gas that looses.These article contain volatile oil, and local anesthetic action is arranged.
Rhizoma Et Radix Notopterygii: expelling cold and relieving exterior syndrome, it is stronger that effect is delivered in rising, acts on the top layer of skin, makes partial telangiectasis, looses, is longer than the wet heresy of cold expelling outside evil being prone to.
Radix Angelicae Pubescentis: removing dampness to relieve pain, be good at the damp eliminating victory and wet, and can the pain relieving cold expelling.Also be the top layer that acts on skin, make the permeability increase of surface skin and help interior cold, be easy to scatter.
Flos Carthami: promoting blood circulation to restore menstrual flow, be used for the few abdomen pain of blood stasis property, abdomen enclosed mass, stasis-dispelling and pain-killing, be used for the pain due to the blood stasis.
Sanguis Draxonis: the clots absorbing pain relieving, go into the Liver Channel blood system, be used for the pain of qi depression to blood stasis, can invigorate blood circulation, interior blood trouble gather stomachache gynecological stasis of blood resistance etc. all desirable it.
Cortex schizophragmatis integrifolii radicis: sour in the mouth is warm in nature, the endogenous dampness of dispelling, the meridian dredging.
The Radix Angelicae Dahuricae: go into stomach, large intestine, lung meridian, dispersing cold for relieving pain, the removing dampness leukorrhagia stopping is used for women's cold-damp leucorrhea.These article have the merit of dispelling cold and removing dampness.Fragrance again can on reach sensiblely, removing dampness is turbid.It is the advantages of good skin penetrating agent.
Folium Artemisiae Argyi: dispelling cold and removing dampness is used for women's cold womb leukorrhagia stomachache.Warming the meridian for stopping bleeding: be used for deficiency and coldness property pain, get the merit of its cold expelling.
Radix Paeoniae Rubra: removing heat from blood and promoting blood circulation, be used for the clot stasis of blood and stagnate, stasis-dispelling and pain-killing, it is long-pending to be used for Blood stasis, and the stasis of blood stagnates and suffers from abdominal pain.
Herba Taxilli: dispelling wind and removing obstruction in the collateral, nourishing blood and preventing abortion has blood pressure lowering and diuresis, and the pressure in the inflammation is reduced, and diuresis can make damp discharge from urine.
Cortex Acanthopancis: expelling wind and removing dampness; Pathogenic warmth wins
partially, and the contracture person that heavily swells and ache uses it.
Windproof: the wind that looses, windproof, win wet.The property buoyance lift benefaction whole body that looses make the wet or wind of pathological changes part each can the dehumidifying part be discharged damp through whole body.
Olibanum (processed): the blood that disappears, pain relieving, detumescence, ability ventilation meridian, activating blood circulation and dissipating blood stasis, stagnation resolvation blood then pain alive is ended.
Myrrha (processed): it is strong that hardship is let out power, the clots absorbing blood that looses.The effect that suppresses the uterus excess secretion is arranged again.
Herba speranskiae tuberculatae: the softening the hard mass painful abdominal mass that disappears is used to gather mass in the abdomen.
Note: used some to seem the medicine that is not the treatment primary disease in this prescription; But in the medicine that is of little use, playing effect and some medicines are arranged according to the principle of external treatment with Chinese medicine is medicine for rheumatisms; Because fatty tissue is thicker here; If single be difficult to pass fatty barrier (just water is many at ordinary times the muscle) with medicine commonly used and use medicine for rheumatism exactly in order to overcome this shortcoming, so use it.
The Chinese medicine for external application of treatment chronic pelvic inflammatory disease of the present invention, scientific and precise, specific aim is more intense, and therapeutic effect is good, and through clinical application for many years, total effective rate is about 90%, and curative effect is very good.The Chinese medicine for external application of treatment chronic pelvic inflammatory disease of the present invention, used prescription is simple, and cost is low, and is without any side effects.Medicine of the present invention has that good effect, cost are low, advantage such as have no side effect.In addition, technique effect of the present invention also is embodied in: medicine 1. involved in the present invention is clinical commonly used, many with a type medicine, and has no side effect.2. this prescription meets the combination principle of Chinese medicine and patient's psychological characteristics fully.3. there is not contraindication.4. our dosage form and methods for using them is simple, convenient, flexible, and the patient is easy to accept.
The specific embodiment
Below in conjunction with embodiment and clinical data the present invention is further described.
A kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease of embodiment 1 preparation
Prescription is: Rhizoma Homalomenae 6g, Fructus Zanthoxyli 6g, Rhizoma Et Radix Notopterygii 6g, Radix Angelicae Pubescentis 6g, Flos Carthami 6g, Sanguis Draxonis 6g, Cortex schizophragmatis integrifolii radicis 6g, Radix Angelicae Dahuricae 10g, Folium Artemisiae Argyi 10g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 12g, windproof 12g, Olibanum (processed) 12g, Myrrha (processed) 12g, Herba speranskiae tuberculatae 100g.
Method for preparing is: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, promptly get medicated powder.
During treatment, medicated powder is packed in the gauze bag, after the dry blowing in the affected part hot compress, each about 30 minutes, once a day, each agent, 15 days is a course of treatment, can cure general 1～3 course of treatment.
A kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease of embodiment 2 preparations
Prescription is: Rhizoma Homalomenae 6g, Fructus Zanthoxyli 6g, Rhizoma Et Radix Notopterygii 6g, Radix Angelicae Pubescentis 6g, Flos Carthami 6g, Sanguis Draxonis 6g, Cortex schizophragmatis integrifolii radicis 6g, Radix Angelicae Dahuricae 10g, Folium Artemisiae Argyi 10g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 12g, windproof 12g, Olibanum (processed) 12g, Myrrha (processed) 12g, Herba speranskiae tuberculatae 100g.
Method for preparing embodiment 1.
A kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease of embodiment 3 preparations
Prescription is: Rhizoma Homalomenae 15g, Fructus Zanthoxyli 15g, Rhizoma Et Radix Notopterygii 15g, Radix Angelicae Pubescentis 15g, Flos Carthami 15g, Sanguis Draxonis 15g, Cortex schizophragmatis integrifolii radicis 15g, Radix Angelicae Dahuricae 15g, Folium Artemisiae Argyi 15g, Radix Paeoniae Rubra 15g, Herba Taxilli 15g, Cortex Acanthopancis 15g, windproof 15g, Olibanum (processed) 15g, Myrrha (processed) 15g, Herba speranskiae tuberculatae 150g.
Method for preparing is with embodiment 1.
Clinical data:
Patient's data: selected 80 routine patients all are the out-patient of Liaocheng City the People's Hospital, and (clinical symptoms: heating is shivered, the tenesmus of lower abdomen dull pain, lumbosacral aching pain all to suffer from chronic pelvic inflammatory disease; Leucorrhea is many, sexual anhedonia), wherein between 20～45 years old age; Average 32.5 years old, the course of disease was the longest 8 years, the shortest person half a year.Be divided into matched group and treatment group at random.Two groups are not had significant difference, have comparability in age, the course of disease, the state of an illness.
Therapeutic modality: matched group adopts treatment of conventional antibiotic medicine and external application crude salt; The treatment group adopts medicine of the present invention to treat (medicines of embodiment 2 preparations).Treat observe the curative effect after 30 days.
The therapeutic evaluation standard:
Effectively: clinical symptom disappearance or basic the disappearance.
Invalid: clinical symptoms no change or do not have significant change.
The result: the therapeutic outcome of matched group and treatment group is as shown in table 1, and the patient all has no adverse reaction during the treatment.
Table 1 liang group clinical data relatively
Can find out that by above-mentioned table 1 effect of treatment group obviously is superior to matched group.
Case 1: Shen, woman, 45 years old, workman.Suffering from acute pelvic inflammatory disease before 3 years recovers behind infusion treatment.Hypogastric region dull pain appears over nearly 3 months, sx when cold whenever, and menstrual period are undesired, and clot is arranged, and leucorrhea is many.De Wenzeshu, thready and stringy pulse.Inspection: hypogastric region tenderness, tenderness, no rebound tenderness.Advise it to use medicine of the present invention (embodiment 2 preparations) and treat, behind the first quarter moon, symptom obviously alleviates, and continues and uses first quarter moon, and all symptoms all disappear.Follow up a case by regular visits to not recurrence in 1 year.
Case 2: Zhu, the woman, 25 years old, teacher lower abdominal pain occurred after cause was born child in 2 years, because of not taking notice of very much at that time, not treatment.Closely over the past half year, symptom increases the weight of to some extent, changes with feelings will and suffers from cold relevant.Back infusion treatment but poor effect are satisfied and are come the inventor to locate to go to a doctor.With medicine of the present invention (embodiment 2 preparations) treatment, symptom obviously alleviates after 5 days, continues with 20 days, and all transference cures are followed up a case by regular visits to and do not recurred half a year.
Case 3, Wang, woman, 30 years old.Suffered from acute pelvic inflammatory disease before 1 year, after the treatment of locality, recovery from illness.Recur again nearly half a year but suffer from abdominal pain not as weight last time, show as and have a dull ache, the soreness of waist has bearing down, night sx.Treatment is 7 days in this locality, and symptom does not have improvement, examines.Inspection: hypogastric region and adnexa all have tenderness, the low back percussion pain.At ordinary times leucorrhea amount many, flavor arranged.Menoxenia (gently), through treating with medicine of the present invention (embodiment 2 preparations), the lower abdomen tenderness obviously alleviates behind the first quarter moon.This patient dampness is too heavy, continues with 1 month, and above-mentioned symptom all disappears, and follows up a case by regular visits to not recurrence in 2 years.
Case 4, Zhang, woman, 38 years old.3 years cause anger adds overworks, and suffers from acute pelvic inflammatory disease, fully recovers after treating for 2 weeks.Nearly 2 moonrise now abdomen dull pain, bearing downs, the acid back lumbar part pain of also turning sour that expands.Examine, treat with medicine of the present invention (embodiment 1 preparation), transference cure after 20 days is followed up a case by regular visits to not recurrence in 8 months.
Case 5 is permitted certain, woman, 35 years old, peasant.2 years causes are overworked and hypogastralgia (mild symptoms) occurred, not treatment.Nearly 3 moonrise abdomen pain now, the time heavy when light, and with leucorrhoea grow in quantity, waist tenesmus, the acid sense of expanding.Be diagnosed as chronic pelvic inflammatory disease.Advise with medicine of the present invention (embodiment 3 preparations) and treat, above-mentioned symptom obviously alleviates after 10 days, continues with 15 days, and transference cure is cured.Follow up a case by regular visits to not recurrence in 1 year.
Claims (5)
1. a Chinese medicine for external application of treating chronic pelvic inflammatory disease is characterized in that: be made up of following bulk drugs: 3～9 parts of Rhizoma Homalomenaes, 3～9 parts of Fructus Zanthoxylis, 3～9 parts of Rhizoma Et Radix Notopterygiis, 3～9 parts of Radix Angelicae Pubescentiss; 3～9 parts on Flos Carthami, 3～9 parts of Sanguis Draxonis, 3～9 parts of Cortex schizophragmatis integrifolii radiciss, 5～15 parts of the Radixs Angelicae Dahuricae; 5～15 parts of Folium Artemisiae Argyis, 9～15 parts of Radix Paeoniae Rubra, 9～15 parts of Herba Taxillis, 9～15 parts of Cortex Acanthopanciss; Windproof 9～15 parts, 9～10 parts of Olibanum (processed)s, 9～15 parts of Myrrha (processed)s, 50～150 parts of Herba speranskiae tuberculataes.
2. a kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Rhizoma Homalomenae 3g, Fructus Zanthoxyli 3g, Rhizoma Et Radix Notopterygii 3g, Radix Angelicae Pubescentis 3g; Flos Carthami 3g, Sanguis Draxonis 3g, Cortex schizophragmatis integrifolii radicis 3g, Radix Angelicae Dahuricae 5g; Folium Artemisiae Argyi 5g, Radix Paeoniae Rubra 9g, Herba Taxilli 9g, Cortex Acanthopancis 9g; Windproof 9g, Olibanum (processed) 9g, Myrrha (processed) 9g, Herba speranskiae tuberculatae 50g.
3. a kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Rhizoma Homalomenae 6g, Fructus Zanthoxyli 6g, Rhizoma Et Radix Notopterygii 6g, Radix Angelicae Pubescentis 6g; Flos Carthami 6g, Sanguis Draxonis 6g, Cortex schizophragmatis integrifolii radicis 6g, Radix Angelicae Dahuricae 10g; Folium Artemisiae Argyi 10g, Radix Paeoniae Rubra 12g, Herba Taxilli 12g, Cortex Acanthopancis 12g; Windproof 12g, Olibanum (processed) 12g, Myrrha (processed) 12g, Herba speranskiae tuberculatae 100g.
4. a kind of Chinese medicine for external application of treating chronic pelvic inflammatory disease according to claim 1 is characterized in that: be made up of following crude drug: Rhizoma Homalomenae 15g, Fructus Zanthoxyli 15g, Rhizoma Et Radix Notopterygii 15g, Radix Angelicae Pubescentis 15g; Flos Carthami 15g, Sanguis Draxonis 15g, Cortex schizophragmatis integrifolii radicis 15g, Radix Angelicae Dahuricae 15g; Folium Artemisiae Argyi 15g, Radix Paeoniae Rubra 15g, Herba Taxilli 15g, Cortex Acanthopancis 15g; Windproof 15g, Olibanum (processed) 15g, Myrrha (processed) 15g, Herba speranskiae tuberculatae 150g.
5. the method for preparing of the Chinese medicine for external application of each described treatment chronic pelvic inflammatory disease in the claim 1～4 is characterized in that: get each crude drug, pulverize and be powdery, cross 200 mesh sieves, mix, promptly get.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100212218A CN102526398A (en) | 2012-01-17 | 2012-01-17 | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100212218A CN102526398A (en) | 2012-01-17 | 2012-01-17 | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102526398A true CN102526398A (en) | 2012-07-04 |
Family
ID=46335218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100212218A Pending CN102526398A (en) | 2012-01-17 | 2012-01-17 | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526398A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006960A (en) * | 2012-12-05 | 2013-04-03 | 姜晶 | Traditional Chinese medicine hot compress bag for curing gynecologic abdominal mass and preparation method of traditional Chinese medicine hot compress bag |
| CN103099901A (en) * | 2013-01-26 | 2013-05-15 | 郭允娟 | Traditional Chinese medicine enema for treating endometriosis |
| CN105920238A (en) * | 2016-05-20 | 2016-09-07 | 烟台民望机电技术有限公司 | Medicine for treating Qi-stagnation and blood stasis type pelvic inflammation and preparation method thereof |
| CN107375595A (en) * | 2017-08-08 | 2017-11-24 | 张蓓 | A kind of Chinese medicine composition for warm the womb |
| CN107397936A (en) * | 2017-07-26 | 2017-11-28 | 荆门市第二人民医院 | A kind of Chinese prescription for treating chronic pelvic inflammatory disease |
| CN112190679A (en) * | 2020-10-21 | 2021-01-08 | 张登山 | External application agent for treating uterus cold type pelvic inflammation and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007099396A2 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
| WO2009007785A2 (en) * | 2006-11-14 | 2009-01-15 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| US20100080822A1 (en) * | 2000-09-13 | 2010-04-01 | Jiangsu Kanion Pharmaceutical Co., Ltd. | Cinnamomi and poria composition, method to prepare same and uses thereof |
| CN101744956A (en) * | 2008-12-11 | 2010-06-23 | 董根荣 | Medicinal composition for treating pelvic inflammation and preparation method thereof |
| CN101966125A (en) * | 2010-10-26 | 2011-02-09 | 江西中医学院附属医院 | Thermosensitive moxibustion moxa stick capable of efficiently stimulating meridian qi transmission and preparation method thereof |
-
2012
- 2012-01-17 CN CN2012100212218A patent/CN102526398A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100080822A1 (en) * | 2000-09-13 | 2010-04-01 | Jiangsu Kanion Pharmaceutical Co., Ltd. | Cinnamomi and poria composition, method to prepare same and uses thereof |
| WO2007099396A2 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
| WO2009007785A2 (en) * | 2006-11-14 | 2009-01-15 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| CN101744956A (en) * | 2008-12-11 | 2010-06-23 | 董根荣 | Medicinal composition for treating pelvic inflammation and preparation method thereof |
| CN101966125A (en) * | 2010-10-26 | 2011-02-09 | 江西中医学院附属医院 | Thermosensitive moxibustion moxa stick capable of efficiently stimulating meridian qi transmission and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 李辉等: "中药外敷治疗慢性***150例报告", 《四川中医》 * |
| 郑红妹: "外治法治疗慢性***研究进展", 《江西中医药》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006960A (en) * | 2012-12-05 | 2013-04-03 | 姜晶 | Traditional Chinese medicine hot compress bag for curing gynecologic abdominal mass and preparation method of traditional Chinese medicine hot compress bag |
| CN103099901A (en) * | 2013-01-26 | 2013-05-15 | 郭允娟 | Traditional Chinese medicine enema for treating endometriosis |
| CN105920238A (en) * | 2016-05-20 | 2016-09-07 | 烟台民望机电技术有限公司 | Medicine for treating Qi-stagnation and blood stasis type pelvic inflammation and preparation method thereof |
| CN107397936A (en) * | 2017-07-26 | 2017-11-28 | 荆门市第二人民医院 | A kind of Chinese prescription for treating chronic pelvic inflammatory disease |
| CN107375595A (en) * | 2017-08-08 | 2017-11-24 | 张蓓 | A kind of Chinese medicine composition for warm the womb |
| CN112190679A (en) * | 2020-10-21 | 2021-01-08 | 张登山 | External application agent for treating uterus cold type pelvic inflammation and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103599494A (en) | Externally applied traditional Chinese medicine for treatment of cervical spondylosis | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102526398A (en) | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation | |
| CN103536858A (en) | Medicine for treating rheumatoid arthritis | |
| CN103211932A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN103599472B (en) | A kind of Chinese medicine composition being used for the treatment of prostatic hyperplasia | |
| CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
| CN104258304A (en) | Medicated wine for meridian unblocking, wind dispelling, collaterals activating and pain relieving | |
| CN103599286A (en) | Traditional Chinese medicine composition for treating fibroid | |
| CN102614487A (en) | Plaster for treatment of prostate and uracratia | |
| CN103585273B (en) | Traditional Chinese medicine composition for treating local swelling and pain | |
| CN103550708B (en) | Chinese herbal compound for treating dysmenorrheal | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN1292764C (en) | Chinese medicinal pill for treating postpartum disease and gynecopathy | |
| CN103223012B (en) | External traditional Chinese medicine composition for treating sudden sprain in lumbar region and acute chest pain and preparation method thereof | |
| CN103356959B (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN101869622A (en) | External patch for treating female pelvic inflammation and preparation method thereof | |
| CN100588414C (en) | Chinese medicine compound for oral administration for treating chronicity nephritis | |
| CN103989885A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation | |
| CN105343707A (en) | Traditional Chinese medicine used for treating erythema annulare centrifugum | |
| CN104474096A (en) | Traditional Chinese medicine composition for treating anal eczema and preparation method of traditional Chinese medicine composition | |
| CN105148051A (en) | Traditional Chinese medicinal composition for treating chronic prostatitis | |
| CN105148050A (en) | Traditional Chinese medicinal composition for treating kidney stone | |
| CN104740040A (en) | Traditional Chinese medicine decoction for treating irregular menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120704 |